Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1244
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMrs.Chudamani B-
dc.date.accessioned2022-12-22T08:18:14Z-
dc.date.available2022-12-22T08:18:14Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1244-
dc.description.abstractCancer is responsible for millions of death every year. The drugs used to treat cancer bear severe side-effects. Hence, there is always a need for effective and safer molecules against it. It can be achieved either by screening the NCE or repurposing the existing one. The bioisosteric replacement on a synthetically versatile scaffold often gives the molecule with desired biological properties. In-silico analysis of existing drugs is also in use to find new anticancer moiety. Cell line based study, heterocyclic synthesis and CADD play vital role inthe process. Objectives: Objectives of the work is to design, synthesize and screen 2,6-substituted-imidazo[2,1-b] [1,3,4]thiadiazoles as levamisole derivativewith desired cytotoxic property and convert them to a potential lead against cancer.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subject2-Aralkyl-6-aryl-imidazo[2,1-b][1,3,4]thiadiazole;Cytotoxicity;Apoptosis; Caspase-3; DNA fragmentation;Levamisole;Melplhalanen_US
dc.titleSynthesis Of Levamisole Derivatives For Anti Cancer Activityen_US
dc.typePhd Thesisen_US
Appears in Collections:Faculty of Pharmacy

Files in This Item:
File Description SizeFormat 
Chudamani B.pdf5.6 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.